NCT02908555

Brief Summary

The purpose of this exploratory study is to evaluate the characteristics of sleep, perceptions of barriers and facilitators to adequate sleep, and the associations among sleep characteristics, executive functioning, coping, adherence, 24-hour glucose levels, and adjustment in adolescents with type 1 diabetes. A mixed methods approach that includes a quantitative component, consisting of actigraphy and sleep diaries, questionnaires, tests of executive function and continuous glucose monitoring (CGM) as well as a narrative qualitative component will be used. Results from this pilot study will be used to provide the effect sizes needed for a larger-scale descriptive study and to establish the need for a possible sleep-promoting intervention for adolescents with type 1 diabetes. This project is consistent with ongoing research focused on developing preventive, behavioral interventions for youth with type 1 diabetes and their families to improve physiological (i.e., glycemic control) and psychological (i.e., quality of life) outcomes. Sleep promotion may become an important component of these interventions. Thus, the following specific aims will be addressed:

  1. 1.Describe the objective and subjective characteristics of sleep (duration, continuity, bed time/rise times); sleep quality and sleep habits among adolescents with type 1 diabetes.
  2. 2.Explore the relationship between characteristics of self-reported sleep (i.e., habits, duration, daytime sleepiness) and executive function, coping, adherence, and adjustment (i.e., depressive symptoms, quality of life) in adolescents with type 1 diabetes.
  3. 3.Explore the relationship of glucose excursions on sleep characteristics and executive functioning.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

September 8, 2016

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 21, 2016

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2018

Completed
Last Updated

July 2, 2018

Status Verified

June 1, 2018

Enrollment Period

2.5 years

First QC Date

September 8, 2016

Last Update Submit

June 28, 2018

Conditions

Keywords

type 1 diabetesadolescentssleep

Outcome Measures

Primary Outcomes (1)

  • Glycemic control

    Hemoglobin A1C

    baseline

Secondary Outcomes (1)

  • Executive functioning

    baseline

Study Arms (1)

no intervention

Descriptive study without groups

Other: No intervention

Interventions

This is a descriptive study with no intervention

no intervention

Eligibility Criteria

Age10 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

40 youth with type 1 diabetes, age 10-16 years, diagnosed for at least 6 months

You may qualify if:

  • diagnosed for at least 6 months

You may not qualify if:

  • able to comply with protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale School of Nursing

West Haven, Connecticut, 06516-0972, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Margaret Grey, DrPH

    Yale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 8, 2016

First Posted

September 21, 2016

Study Start

January 1, 2016

Primary Completion

June 15, 2018

Study Completion

June 15, 2018

Last Updated

July 2, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will share

De-identified data will be shared once analyses are final.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
1 year after data collection is complete
Access Criteria
By request to principal investigator

Locations